Oncophenomics
Oncophenomics is a personalized medicine company specializing in advanced liquid biopsy tests that enable early cancer detection and personalized treatment selection. Their innovative technology integrates genomic and epigenomic biomarkers, allowing for tailored therapies that significantly improve patient outcomes. By leveraging artificial intelligence and machine learning, Oncophenomics aims to revolutionize cancer diagnostics and treatment, positioning itself as a leader in precision oncology. The company collaborates with biotech firms, biopharma, cancer hospitals, and oncologists to enhance clinical outcomes and support clinical trials.
Oncophenomics
Oncophenomics is a personalized medicine company specializing in advanced liquid biopsy tests that enable early cancer detection and personalized treatment selection. Their innovative technology integrates genomic and epigenomic biomarkers, allowing for tailored therapies that significantly improve patient outcomes. By leveraging artificial intelligence and machine learning, Oncophenomics aims to revolutionize cancer diagnostics and treatment, positioning itself as a leader in precision oncology. The company collaborates with biotech firms, biopharma, cancer hospitals, and oncologists to enhance clinical outcomes and support clinical trials.